查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1983949

医学影像市场：2026-2032年全球市场预测（依影像方式、组件、技术类型、最终用户和应用划分）

Diagnostic Imaging Market by Modality, Component, Technology Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗影像市场价值将达到 296.5 亿美元，到 2026 年将成长至 313.1 亿美元，到 2032 年将达到 435.3 亿美元，复合年增长率为 5.64%。

主要市场统计数据
基准年 2025 296.5亿美元
预计年份：2026年 313.1亿美元
预测年份：2032年 435.3亿美元
复合年增长率 (%) 5.64%

针对不断发展的诊断影像生态系统提供权威指导，重点在于临床优先事项、技术整合和采购实际情况，以便做出明智的决策。

诊断影像领域正经历一场变革，技术、​​监管和组织等多面向因素的整合加速了这项变革。医疗服务提供者和技术供应商都面临着提升临床处理能力、提高诊断准确性以及在整个诊疗过程中展现价值的压力。同时，硬体小型化、高阶软体分析和云端工作流程等方面的创新正在重塑诊断成像服务的交付和使用方式。

对人工智慧、模组化硬体、资料互通性和监管奖励如何重塑诊断成像交付和供应商策略进行清晰分析。

在诊断影像领域，一场变革正在发生，它重新定义了资本密集型设备与软体主导的临床支援之间的平衡。先进的分析技术和人工智慧模型正从概念验证（PoC）阶段走向常规临床支持，在许多医疗机构中得到应用，加速了工作流程自动化、影像重建、关键观察的优先排序以及处方笺格式报告的生成。这些功能重新激发了人们对软体优先策略和供应商伙伴关係的兴趣，这些策略和合作将设备功能与云端原生分析相结合。

2025 年的关税环境将如何重塑整个诊断影像生态系统的采购趋势、供应商策略和供应链韧性？

2025年关税和贸易措施的实施给诊断影像设备及其组件的整个供应链和采购管道带来了巨大压力。关税上涨及相关的合规要求延长了前置作业时间，尤其是那些从地理位置集中的供应商采购的关键组件和子系统。医疗服务提供者和供应商被迫调整价格、重新谈判供应商合约并修改库存策略，以维持服务的连续性并确保资金用于患者照护。

从详细的观点揭示了影响临床采用和采购选择的模式、组件、最终用户、应用和技术类型的趋势。

深入的市场细分揭示了临床需求与技术能力相符的领域，以及投资能带来最大营运效益的领域。检验不同影像方式的差异可知，电脑放射影像（CT）包括锥状射束CT、常规CT和可携式CT，每种CT在门诊、急诊和术中环境中都具有独特的提案。磁振造影（MRI）涵盖高场MRI、低场MRI和超高场MRI，在空间解析度、可及性和营运成本之间各有优劣。核子医学分为专门的正子断层扫描（PET）和单光子发射断层扫描（SPECT），它们驱动肿瘤学和循环系统的通讯协定；而超音波技术（从二维到超音波、超音波和超音波）的应用范围十分广泛，从临床分诊到高级介入影像均有涉及。 X射线透过不断发展的电脑放射成像（CR）数位放射线（DR）继续发挥基础性作用，这两种成像方式优先考虑剂量效率和快速的数位化工作流程。

美洲、欧洲、中东和非洲以及亚太地区的实施模式、监管复杂性和采购趋势的区域策略分析

受报销模式、管理体制和製造地等因素的影响，区域趋势持续影响不同地区的普及程度，有的地区普及速度趋于平缓，有的地区则成长加速。在美洲，对企业影像、人工智慧整合和基于价值的医疗服务的投资，优先考虑临床疗效和效率，推动大规模医疗系统采用先进技术，同时也催生了区域医院和门诊中心对中端设备的需求。公共和私人支付方结构影响采购时机和资金分配，进一步凸显了证明治疗效果和处理能力提升的证据的重要性。

对现有硬体公司、软体挑战者和服务型供应商的竞争策略、伙伴关係和能力投资进行评估性概述，以区分它们。

诊断影像领域的竞争格局呈现出多元化的特点，既有成熟的硬体公司，也有快速发展的软体专家，以及不断壮大的服务供应商生态系统。成熟的设备製造商持续投资于平台现代化和现场服务改进，以保护其现有设备基础并扩大服务主导收入。同时，软体主导的新兴参与企业和人工智慧专家正力图在临床决策支援、影像校正和工作流程自动化等领域主导地位，迫使现有供应商透过建立伙伴关係、进行收购或开发内部分析能力来规避竞争。

一项可行的分阶段策略，旨在加强供应韧性，实现软体和服务货币化，并使证据产生与支付方和监管机构的期望保持一致。

行业领导企业应采取一系列切实可行的分阶段措施，以应对动盪的市场形势，并从持续的技术变革中获益。首先，应优先提升供应链韧性，具体措施包括供应商多元化、选择替代零件来源以及引入能够应对贸易政策波动的灵活合约条款。这将有助于降低交货风险，确保临床客户的业务连续性。

透过严谨且多方面的研究途径，结合与关键相关人员的访谈、技术检验和情境分析，得出与决策直接相关的见解。

本研究采用综合分析调查方法，强调关键相关人员意见、技术文件和观察分析的三角验证，从而确保研究结果的稳健性和可操作性。主要研究包括对临床负责人、采购负责人、现场工程师和技术主管进行结构化访谈，以收集关于特定设备性能、服务挑战和部署障碍的第一手观点。此外，还参考了技术白皮书、监管文件和产品文檔，以检验设备功能和合规性的演变。

为了确保诊断成像领域的长期价值，我们正在透过简洁地整合关键优先事项，将技术创新、临床结果和稳健的营运相结合。

诊断影像领域正处于一个转折点，技术创新、服务模式和政策环境在此交汇，重新定义了临床影像诊断的价值。如今，在供应链建构、软体整合和服务能力方面的策略性选择，将决定哪些机构能够获得临床价值并保持竞争优势。那些能够从系统观点出发，平衡硬体效能、软体驱动的工作流程、人才储备和资金筹措的相关人员，更有可能占据优势。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：诊断影像市场：依影像方式划分

  • 电脑放射成像
    • 锥状射束CT
    • 常规电脑放射成像
    • 携带式电脑放射成像
  • 磁振造影
    • 高场磁振造影
    • 低场磁振造影
    • 超高场磁振造影
  • 核子医学
    • 正子断层扫描
    • 单光子发射断层扫描
  • 超音波
    • 二维超音波
    • 三维超音波
    • 4D超音波
    • 多普勒超音波
  • X射线
    • 电脑放射成像
    • 数位放射线摄影

第九章：诊断影像市场：按组件划分

  • 硬体
    • 线圈
    • 检测器
    • 发电机
    • 感应器
  • 服务
    • 咨询
    • 安装
    • 维护
    • 训练
  • 软体
    • 人工智慧分析
    • PACS
    • 报告创建软体
    • RIS

第十章：诊断影像市场：依技术类型划分

  • 二维影像诊断
  • 三维影像诊断
  • 4D影像诊断

第十一章 医疗影像市场：依最终使用者划分

  • 诊所
  • 诊断中心
  • 医院
  • 研究机构

第十二章：医疗影像市场：依应用领域划分

  • 循环系统
  • 牙科
  • 神经病学
  • 妇产科
  • 肿瘤学
  • 眼科
  • 整形外科

第十三章：诊断影像市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：诊断影像市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：诊断影像市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医疗影像市场

第十七章：中国医疗影像市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Allengers Medical Systems Ltd.
  • Analogic Corporation
  • Aurora Imaging Technologies, Inc.
  • BK Medical A/S
  • Bracco SpA
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • CurveBeam LLC
  • Esaote SpA
  • Fonar Corporation
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Neusoft Medical Systems Co., Ltd.
  • Planmed Oy
  • Quibim, SL
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
Product Code: MRR-CF6C60CF95AA

The Diagnostic Imaging Market was valued at USD 29.65 billion in 2025 and is projected to grow to USD 31.31 billion in 2026, with a CAGR of 5.64%, reaching USD 43.53 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 29.65 billion
Estimated Year [2026] USD 31.31 billion
Forecast Year [2032] USD 43.53 billion
CAGR (%) 5.64%

An authoritative orientation to the evolving diagnostic imaging ecosystem highlighting clinical priorities, technology convergence, and procurement realities for informed decision-making

The diagnostic imaging landscape is in a period of accelerated transformation driven by converging technological, regulatory, and organizational forces. Healthcare providers and technology vendors alike face mounting pressure to improve clinical throughput, enhance diagnostic accuracy, and demonstrate value across episodes of care. At the same time, innovation in hardware miniaturization, advanced software analytics, and cloud-enabled workflows is reshaping how imaging services are delivered and consumed.

This executive summary orients leaders to the structural changes affecting clinical imaging programs and supplier strategies. It synthesizes cross-cutting themes that matter most to decision-makers responsible for capital planning, clinical integration, and vendor selection. The intent is to provide a concise, evidence-based primer that highlights risks, strategic levers, and near-term operational priorities without presuming a single one-size-fits-all solution.

Readers will find a balanced discussion that connects modality-specific advances to broader trends in software, services, and regulatory pathways. The narrative emphasizes practical implications for procurement cycles, clinical adoption, and organizational readiness, and outlines recommended strategic responses that preserve clinical quality while enabling cost-effective modernization. By grounding strategic choices in operational realities, the introduction sets the stage for deeper examination of shifts, policy impacts, segmentation nuances, regional dynamics, and recommended actions.

A clear-eyed analysis of how AI, modular hardware, data interoperability, and regulatory incentives are reshaping diagnostic imaging delivery and vendor strategies

Diagnostic imaging is undergoing transformative shifts that are redefining the balance between capital-intensive equipment and software-driven clinical augmentation. Advanced analytics and AI models have moved beyond proof-of-concept to routine clinical augmentation in many centers, accelerating workflow automation, image reconstruction, prioritization of critical findings, and prescriptive reporting. These capabilities are driving renewed interest in software-first strategies and vendor partnerships that blend device performance with cloud-native analytics.

Simultaneously, hardware evolution is focusing on portability, lower-field magnetic resonance systems, modular computed tomography platforms, and point-of-care ultrasound arrays that enable decentralized diagnostics. These hardware trends are complemented by improvements in detector sensitivity and image processing that reduce radiation exposure and improve patient comfort, thereby influencing clinical protocols and utilization patterns. Convergence between imaging modalities and interventional procedures is intensifying as imaging platforms increasingly support therapeutics, image-guided interventions, and hybrid operating room workflows.

Operationally, interoperability and data governance have emerged as central imperatives; institutions demand systems that integrate with electronic health records and clinical decision support while maintaining cybersecurity and patient privacy. Suppliers are responding with federated learning approaches, encrypted data exchange, and tighter integration frameworks. Finally, regulatory pathways and value-based reimbursement models are incentivizing quantifiable improvements in patient outcomes and throughput, shifting procurement decisions toward demonstrable clinical and economic value rather than purely technical specifications.

How the 2025 tariff environment has reshaped procurement dynamics, supplier strategies, and supply chain resilience across diagnostic imaging ecosystems

The introduction of tariffs and trade measures in 2025 imposed material pressures across supply chains and procurement pathways for diagnostic imaging equipment and components. Increased duties and related compliance requirements have amplified lead times for critical assemblies and subsystems, particularly those sourced from geographically concentrated suppliers. Providers and vendors have had to navigate price adjustments, renegotiate supplier contracts, and reassess inventory strategies to maintain service continuity and preserve capital allocation toward patient care.

In practical terms, tariffs affected both end-equipment pricing and component-level economics, prompting manufacturers to evaluate alternate sourcing, regionalize production where feasible, and accelerate design changes that reduce reliance on tariff-affected parts. The cumulative effect tightened margins for some suppliers while catalyzing investment in supply chain resilience. For healthcare organizations, procurement cycles lengthened as contract teams incorporated tariff clauses and contingency planning into RFPs, and capital committees weighed the timing of purchases against potential cost volatility.

Beyond procurement, the tariff environment influenced strategic partner selection and innovation roadmaps. Vendors with diversified manufacturing footprints and robust services networks were better positioned to absorb incremental costs and maintain delivery commitments. Meanwhile, smaller suppliers faced intensified pressure to reprice or pivot toward service-oriented models. Overall, the 2025 tariff landscape reinforced the strategic importance of supply chain due diligence, flexible contracting, and collaborative vendor relationships that prioritize transparency and shared risk mitigation.

A granular segmentation-based perspective revealing modality, component, end-user, application, and technology type dynamics that drive clinical adoption and procurement choices

Insightful segmentation reveals where clinical demand aligns with technological capability and where investment will unlock the greatest operational leverage. When examining modality distinctions, computed tomography spans cone beam computed tomography, conventional computed tomography, and portable computed tomography each with distinct value propositions in ambulatory, emergency, and intraoperative settings. Magnetic resonance imaging encompasses high-field magnetic resonance imaging, low-field magnetic resonance imaging, and ultra-high-field magnetic resonance imaging, with trade-offs among spatial resolution, accessibility, and cost to operate. Nuclear medicine divides into positron emission tomography and single photon emission computed tomography specialties that drive oncology and cardiology protocols, while ultrasound technologies-from 2D ultrasound to 3D ultrasound, 4D ultrasound, and Doppler ultrasound-serve a broad continuum from point-of-care triage to sophisticated interventional imaging. X-ray remains foundational through computed radiography and digital radiography formats that continue to evolve toward dose efficiency and rapid digital workflows.

Component-level segmentation frames where margins, service intensity, and upgrade cycles concentrate. Hardware elements such as coils, detectors, generators, and transducers determine baseline image quality and TCO, while services including consulting, installation, maintenance, and training underpin uptime and clinician adoption. Software suites composed of AI analytics, PACS, reporting software, and RIS increasingly act as differentiators for longitudinal clinical value, enabling diagnostics to scale across distributed settings. End-user segmentation captures heterogeneity in purchasing behavior and utilization patterns: clinics prioritize throughput and affordability, diagnostic centers focus on throughput and niche services, hospitals balance breadth of modalities with integration into complex care pathways, and research institutes emphasize experimental capability and advanced modality support. Application-based segmentation highlights where modality and software investments yield clinical impact across cardiology, dental, neurology, obstetrics and gynecology, oncology, ophthalmology, and orthopedics, each with unique imaging protocols and regulatory considerations. Finally, technology-type segmentation spanning 2D imaging, 3D imaging, and 4D imaging frames the progression from planar diagnostics to volumetric and temporal analyses that support procedural planning and longitudinal monitoring.

Taken together, these segmentation layers illuminate strategic vectors for suppliers and providers: modular hardware investments should align with the dominant clinical use cases of each end-user type, software and services must be tailored to modality-specific workflows, and training and maintenance offerings must scale to the technical complexity of advanced imaging types. Integrating segmentation intelligence into procurement and product roadmaps enables targeted innovation that addresses differential clinical value across settings and specialties.

A regional strategic breakdown of adoption patterns, regulatory complexity, and procurement behavior across the Americas, Europe Middle East & Africa, and Asia-Pacific landscapes

Regional dynamics continue to shape where adoption plateaus and where growth accelerates, driven by reimbursement models, regulatory regimes, and manufacturing footprints. In the Americas, investment in enterprise imaging, AI integration, and value-based care initiatives emphasizes clinical outcomes and efficiency, supporting uptake of advanced modalities in large health systems while also creating demand for mid-tier devices in community hospitals and outpatient centers. Public and private payer structures influence procurement timing and capital allocation, reinforcing the importance of evidence demonstrating improvements in outcomes and throughput.

Across Europe, Middle East & Africa, regulatory harmonization and diverse reimbursement environments create a mosaic of adoption trajectories. Western European centers often lead in early clinical adoption and integration of software-enabled workflows, while many markets in the Middle East invest selectively in high-end modalities for tertiary care hubs. In parts of Africa, capacity constraints and workforce distribution underscore demand for portable and cost-efficient imaging solutions that maximize clinical reach. Vendors that adapt commercial models to local financing structures and prioritize service networks often gain traction in these varied contexts.

In Asia-Pacific, the interplay of domestic manufacturing capabilities, government-led healthcare expansion, and rapid urbanization drives a dual market: sophisticated tertiary centers in urban hubs adopt cutting-edge imaging and hybrid interventional suites, while extensive rural and peri-urban populations create demand for scalable, lower-cost modalities and tele-imaging services. Regional supply chains and local component manufacturing can mitigate tariff exposure and accelerate time-to-market for tailored solutions. Understanding these regional contours is essential to align product strategies, distribution partnerships, and clinical education programs with regional demand and operational realities.

An evaluative overview of competitive strategies, partnerships, and capability investments that differentiate hardware incumbents, software challengers, and service-focused providers

Competitive dynamics in diagnostic imaging are characterized by a blend of established hardware incumbents, fast-growing software specialists, and an expanding ecosystem of services providers. Established equipment manufacturers continue to invest in platform modernization and field service expansion to protect installed bases and extend service-driven revenue. At the same time, software-first entrants and AI specialists push the agenda on clinical decision support, image enhancement, and workflow automation, prompting legacy vendors to pursue partnerships, acquisitions, or in-house analytics development to remain competitive.

Strategic alliances between imaging manufacturers and cloud providers or analytics firms are becoming more common as vendors seek to offer integrated solutions rather than standalone devices. These collaborations prioritize joint go-to-market strategies that bundle hardware with subscription-based software and managed services, aligning incentives around uptime, outcomes, and continuous product improvement. Additionally, companies that build robust training and remote support capabilities differentiate through higher clinician adoption and lower total cost of ownership over the equipment lifecycle.

Mergers and targeted investments continue to reshape the vendor landscape, but differentiation increasingly rests on the ability to demonstrate clinical impact, regulatory compliance, and scalable deployment models. Organizations that excel in field service, data security, and interoperability are more successful at converting pilot projects into enterprise-wide deployments. New entrants that focus on modularity, affordability, and user-centered design find opportunities in outpatient centers and emerging markets, while premium offerings concentrate on high-acuity hospital systems and research facilities.

Actionable, phased strategies to strengthen supply resilience, monetize software and services, and align evidence generation with payer and regulatory expectations

Industry leaders should pursue a set of pragmatic, sequenced actions to navigate turbulence and capture upside from ongoing technological shifts. First, prioritize supply chain resilience by diversifying supplier bases, qualifying alternate component sources, and incorporating flexible contract terms that account for trade policy volatility. This will reduce delivery risk and protect operational continuity for clinical customers.

Second, accelerate software integration and modular design to enable incremental upgrades and subscription-based revenue streams. Organizations that separate hardware lifecycles from software innovation can offer continuous clinical improvements without forcing premature hardware replacement. Third, invest in services and workforce development: scaled installation, preventive maintenance, and clinician training programs increase adoption rates and protect brand reputation. These investments also create recurring revenue and strengthen customer relationships.

Fourth, align product development and evidence generation with payer and regulator expectations by supporting real-world evidence studies, health economic analyses, and interoperability standards. Demonstrating measurable improvements in diagnostic accuracy, time-to-treatment, or workflow efficiency will ease procurement and reimbursement hurdles. Fifth, pursue targeted regional strategies: localize pricing, financing, and service models to reflect regional payer structures and operational realities. Finally, embrace sustainability and lifecycle planning to reduce energy consumption, extend equipment longevity, and respond to institutional ESG commitments. Taken together, these actions create a resilient commercial model that balances innovation with operational reliability.

A rigorous, multi-method research approach combining primary stakeholder interviews, technical validation, and scenario analysis to generate decision-ready insights

This research synthesis relies on a blended methodology that emphasizes triangulation of primary stakeholder input, technical documentation, and observational analysis to ensure robustness and practical relevance. Primary research included structured interviews with clinical leaders, procurement officers, field engineers, and technology executives to capture firsthand perspectives on modality-specific performance, service challenges, and adoption barriers. These qualitative insights were supplemented with technical white papers, regulatory filings, and product literature to validate device capabilities and compliance trajectories.

Analytical approaches incorporated comparative feature mapping across modality types, component lifecycles, and software ecosystems, enabling consistent cross-sectional analysis. Scenario-based evaluation was applied to assess the operational implications of supply chain disruptions, policy shifts, and technology diffusion, while expert panels provided validation of synthesized findings to minimize interpretative bias. Throughout the process, data quality controls included source triangulation, version control for technical specifications, and sensitivity checks for qualitative assertions.

Limitations are acknowledged: proprietary sales data and institution-level procurement contracts were not accessible for confidentiality reasons, and regional heterogeneity means that some operational recommendations should be tailored locally. Nevertheless, the methodology emphasizes transparency, reproducibility, and practical applicability, providing decision-ready insight grounded in current clinical practice and vendor strategies.

A concise synthesis of pivotal priorities that unify technological innovation, clinical outcomes, and resilient operations to secure long-term value in diagnostic imaging

The diagnostic imaging sector stands at an inflection point where technological innovation, service delivery models, and policy environments converge to redefine what clinical imaging can deliver. Strategic choices made today around supply chain architecture, software integration, and service capabilities will determine which organizations capture clinical value and sustain competitive differentiation. Stakeholders that adopt a systems perspective-balancing hardware performance, software-enabled workflows, workforce readiness, and financing mechanisms-will be best positioned to translate innovation into routine clinical benefit.

The most successful pathways emphasize modularity, evidence-backed value propositions, and resilient operational models that can withstand policy and supply shocks. By focusing on interoperability, clinician adoption, and demonstrable improvements in diagnostic outcomes and throughput, providers and vendors can align incentives across the care continuum and enable more predictable procurement cycles. Ultimately, the sector's near-term priorities involve converting pilot-scale innovations into scalable, secure, and clinician-centric solutions that support patient access and institutional objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Diagnostic Imaging Market, by Modality

  • 8.1. Computed Tomography
    • 8.1.1. Cone Beam Computed Tomography
    • 8.1.2. Conventional Computed Tomography
    • 8.1.3. Portable Computed Tomography
  • 8.2. Magnetic Resonance Imaging
    • 8.2.1. High-Field Magnetic Resonance Imaging
    • 8.2.2. Low-Field Magnetic Resonance Imaging
    • 8.2.3. Ultra-High-Field Magnetic Resonance Imaging
  • 8.3. Nuclear Medicine
    • 8.3.1. Positron Emission Tomography
    • 8.3.2. Single Photon Emission Computed Tomography
  • 8.4. Ultrasound
    • 8.4.1. 2D Ultrasound
    • 8.4.2. 3D Ultrasound
    • 8.4.3. 4D Ultrasound
    • 8.4.4. Doppler Ultrasound
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography

9. Diagnostic Imaging Market, by Component

  • 9.1. Hardware
    • 9.1.1. Coils
    • 9.1.2. Detectors
    • 9.1.3. Generators
    • 9.1.4. Transducers
  • 9.2. Services
    • 9.2.1. Consulting
    • 9.2.2. Installation
    • 9.2.3. Maintenance
    • 9.2.4. Training
  • 9.3. Software
    • 9.3.1. AI Analytics
    • 9.3.2. PACS
    • 9.3.3. Reporting Software
    • 9.3.4. RIS

10. Diagnostic Imaging Market, by Technology Type

  • 10.1. 2D Imaging
  • 10.2. 3D Imaging
  • 10.3. 4D Imaging

11. Diagnostic Imaging Market, by End User

  • 11.1. Clinics
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Diagnostic Imaging Market, by Application

  • 12.1. Cardiology
  • 12.2. Dental
  • 12.3. Neurology
  • 12.4. Obstetrics/Gynecology
  • 12.5. Oncology
  • 12.6. Ophthalmology
  • 12.7. Orthopedics

13. Diagnostic Imaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Diagnostic Imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Diagnostic Imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Diagnostic Imaging Market

17. China Diagnostic Imaging Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Allengers Medical Systems Ltd.
  • 18.7. Analogic Corporation
  • 18.8. Aurora Imaging Technologies, Inc.
  • 18.9. BK Medical A/S
  • 18.10. Bracco S.p.A.
  • 18.11. Canon Medical Systems Corporation
  • 18.12. Carestream Health, Inc.
  • 18.13. CurveBeam LLC
  • 18.14. Esaote S.p.A.
  • 18.15. Fonar Corporation
  • 18.16. Fujifilm Holdings Corporation
  • 18.17. GE HealthCare Technologies, Inc.
  • 18.18. Hitachi, Ltd.
  • 18.19. Hologic, Inc.
  • 18.20. Hologic, Inc.
  • 18.21. Koninklijke Philips N.V.
  • 18.22. Mindray Medical International Limited
  • 18.23. Mindray Medical International Limited
  • 18.24. Neusoft Medical Systems Co., Ltd.
  • 18.25. Planmed Oy
  • 18.26. Quibim, S.L.
  • 18.27. Samsung Medison Co., Ltd.
  • 18.28. Samsung Medison Co., Ltd.
  • 18.29. Shimadzu Corporation
  • 18.30. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIAGNOSTIC IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIAGNOSTIC IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 289. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 290. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 291. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 292. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 293. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 294. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 295. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 296. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 297. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 298. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 321. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 322. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 323. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 324. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 325. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 326. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 330. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 331. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 332. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLIO